← FDA Drug Approvals (Drugs@FDA)
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 1988-05-20
Drug application
- FDA Application #
ANDA062759- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
- Generic name
- Erythromycin Ethylsuccinate
- Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
- Dosage form
- GRANULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- BARR
- First approval
- 1988-05-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown